Amrutanjan Health Care Limited

rs,

i 400 051 ISIN: INE098F01031 BSE Limited Department of Corporate Services 1st Floor, P.J. Towers, Dalal Street, Mumbai 400 001 ISIN: INE098F01031 Symbol: AMRUTANJAN Scrip Code: 590006 Dear S

1860 Crore

formance: OTC Head Category Body Category Congestion Category • Category Value (MAT Dec 24*): 1860 Crores. • Category Growth: Value 9.7% and Volume 6.4% (MAT Dec 24*). AHCL’s Volume growth was higher th

9.7%

tegory Congestion Category • Category Value (MAT Dec 24*): 1860 Crores. • Category Growth: Value 9.7% and Volume 6.4% (MAT Dec 24*). AHCL’s Volume growth was higher than the category (7.2%) • Catego

6.4%

on Category • Category Value (MAT Dec 24*): 1860 Crores. • Category Growth: Value 9.7% and Volume 6.4% (MAT Dec 24*). AHCL’s Volume growth was higher than the category (7.2%) • Category Value (MAT De

7.2%

wth: Value 9.7% and Volume 6.4% (MAT Dec 24*). AHCL’s Volume growth was higher than the category (7.2%) • Category Value (MAT Dec 24*): 3590 Crores. • Category Growth: Value 16.5% and Volume 11% (MAT

3590 Crore

c 24*). AHCL’s Volume growth was higher than the category (7.2%) • Category Value (MAT Dec 24*): 3590 Crores. • Category Growth: Value 16.5% and Volume 11% (MAT Dec 24*). AHCL’s Value and Volume growth was

16.5%

r than the category (7.2%) • Category Value (MAT Dec 24*): 3590 Crores. • Category Growth: Value 16.5% and Volume 11% (MAT Dec 24*). AHCL’s Value and Volume growth was higher than the category (18.4%

11%

ry (7.2%) • Category Value (MAT Dec 24*): 3590 Crores. • Category Growth: Value 16.5% and Volume 11% (MAT Dec 24*). AHCL’s Value and Volume growth was higher than the category (18.4% and 19.4% respe

18.4%

16.5% and Volume 11% (MAT Dec 24*). AHCL’s Value and Volume growth was higher than the category (18.4% and 19.4% respectively) • The growth momentum for the category and AHCL continued in Q4 24 (highe

19.4%

Volume 11% (MAT Dec 24*). AHCL’s Value and Volume growth was higher than the category (18.4% and 19.4% respectively) • The growth momentum for the category and AHCL continued in Q4 24 (highest Volume

58%

nessed accelerated growth in Q3 FY 24-25, which reflected in its contribution to AHCL Q3 FY 24-25 58% 3.7% Contribution to AHCL Gr Vs. LY YTD Dec 24 53% 3.3% consistent contribution Contribution to

3.7%

ed accelerated growth in Q3 FY 24-25, which reflected in its contribution to AHCL Q3 FY 24-25 58% 3.7% Contribution to AHCL Gr Vs. LY YTD Dec 24 53% 3.3% consistent contribution Contribution to AHCL

Notes

2

Notes

• Majority of raw material & packing material prices are lower than YTD Dec’23. Menthol Crystal price is marginally lower than YTD Dec’23. • Advertisement for spend YTD Dec’24 is at Rs. 24.70 Cr against Rs. 23.10 Dec’23. Advertisement spend for Comfy is at Rs. 5.37 Cr for YTD Dec’24 against Rs. 4.91 Cr for YTD Dec’23. YTD for Cr Investor Presentation | Quarter and Period Ended 31st December 2024 18 Financials – YTD Dec’24 – Beverage Division (Rs. in Crores) Net Sales - Beverages 18.76 21.32 YTD Dec'24 YTD Dec'23 Net Sales - Electro Plus 16.23 15.33 YTD Dec'24 YTD Dec'23 Growth: 5.87%

Notes

• Raw Material prices are higher when compared to YTD Dec’23. • Packing Material are marginally higher when compared YTD Dec’23. prices • Advertisement spend is at Rs. 3.72 Cr for YTD Dec’24 against Rs. 2.82 Cr for YTD Dec’23. • Business is continuing with cash & carry model for Fruitnik. Investor Presentation | Quarter and Period Ended 31st December 2024 19 Management Commentary Investor Presentation | Quarter and Period Ended 31st December 2024 20 Management Commentary 1. Pain balm consumption volume growth was reported at 9.1% (IQVIA) for December quarter a. This is the highest growth we saw in last 20 quarters barring COVID. b. We see the category returning to double digit growth by q4 of this financial year 2. We saw robust sales pick up in q3 in the Pain Management category 3. Our efforts in improving operational process efficiency in areas like freight has resulted in operating margin expansion of 69 basis points 4. Comfy operating losses have come down considerably from 7.24 cr